IL10 and colitis: In 2000, a natural probiotic, Lactococcus lactis, was genetically modified to constitutively secrete the human anti-inflammatory cytokine protein interleukin-10 (IL-10); when orally administrated in rat models of colitis, a significant reduction of inflammation was assessed [185].